title: [Cholangiocellular carcinoma--clinical features and surgical treatment].
abstract: Cholangiocellular carcinoma is the second on rate primary liver cancer (7-10%), after hepatocellular carcinoma--(80-85%). The aim of this study is to present some diferrencies in clinical and pathological features in comparison to other liver tumors.
  
  
  METHODS
  In the period 1991-2002 years, 105 patients with primary liver cancer were operated; 9 of them (8.5%) had cholangiocellular carcinoma (CCC). The men were 5, the women--4, and the mean age 51 years. Hepatic resection was performed in 5 patients, in 1--biliary drainage, in 3--explorative laparotomy.
  
  
  RESULTS
  Until 30th postoperative day there was no death in resected patients, but one--the drained patient. Morbidity was: ascites, hepatocellular insuficiency, fever. One patient is alive more than 4 years.
  
  
  CONCLUSIONS
  Cholangiocarcinoma affects young people, sometimes they are jaundiced; tumours become big, because asymptomatic grow. Hepatic resection remains to be the best therapeutical option in nonjaundiced patients.
authors.forename: T
authors.initials: T
authors.lastname: Frangov
authors.forename: V
authors.initials: V
authors.lastname: Dimitrova
mesh_terms: D000328:Adult; D000368:Aged; D001650:Bile Duct Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D001653:Bile Ducts, Intrahepatic / Q000601:surgery*; D014408:Biomarkers, Tumor / Q000032:analysis; D018281:Cholangiocarcinoma / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D018572:Disease-Free Survival; D005260:Female; D006498:Hepatectomy; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D014408:Biomarkers, Tumor